Expansion in Teleophthalmology Use for Diabetic Retinopathy Screening During the COVID-19 Pandemic
Telemedicine and e-Health · 2025-08 · 31 (8) · 1019-1026
DOI: 10.1089/tmj.2024.0526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Telemedicine and e-Health, online erschienen am 04.04.2025. Verfasst von Lindsey Nguyen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology & Vision Sciences, University of California, Davis, Sacramento, California, USA. Hauptthemen laut MEDLINE: Diabetic Retinopathy, COVID-19, Telemedicine, Ophthalmology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Introduction
During the COVID-19 pandemic, the University of California, Davis Health (UCDH) system expanded teleophthalmology for diabetic retinopathy (DR) screening through increased sites and personnel, custom workflows, and improved awareness. Here, we report the outcomes of the expansion and investigate disparities during the pandemic lockdown.
Methods
We retrospectively reviewed patients who received remote DR screening to compare demographic, socioeconomic, and clinical differences between individuals who underwent screening before, during, and after the COVID-19 lockdown.
Results
UCDH increased quarterly teleophthalmology visits from 46.4 ± 13.9 before to 253.8 ± 38.0 visits after the COVID-19 lockdown ( p < 0.001), while DR screening rates improved from 51.0 ± 1.5% to 56.9 ± 1.6% over that period ( p = 0.03). During the pandemic, we observed greater proportions of unemployed ( p < 0.001), higher-income ( p < 0.001), geographically nearby ( p = 0.001) patients, and fewer individuals with socioeconomic disadvantage as measured by their area deprivation index ( p = 0.02). Fewer patients with poorly controlled diabetes ( p = 0.014) or hypertension ( p = 0.04) also received remote screening during the pandemic, although most of these disparities were no longer detectable after the initial lockdown.
Discussion
Teleophthalmology expansion at UCDH during the COVID-19 pandemic led to sustained improvements in DR screening. Although some vulnerable individuals had reduced access to teleophthalmology during the initial lockdown, these disparities were not sustained postpandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology & Vision Sciences, University of California, Davis, Sacramento, California, USA.
- Department of Ophthalmology, University of California, San Francisco, California, USA.
- The Proctor Foundation, University of California, San Francisco, California, USA.
ORCID-Profile: Glenn Yiu
Zitieren
APA
Nguyen, L., Jaishankar, T., Chokshi, T., Cruz, M. J., Kim, J., Vargas-Ramos, T., Snyder, B., Hang, A., Guajardo, L., & Yiu, G. (2025). Expansion in Teleophthalmology Use for Diabetic Retinopathy Screening During the COVID-19 Pandemic. Telemedicine and e-Health, 31(8), 1019-1026. https://doi.org/10.1089/tmj.2024.0526
Vancouver
Nguyen L, Jaishankar T, Chokshi T, Cruz MJ, Kim J, Vargas-Ramos T, et al. Expansion in Teleophthalmology Use for Diabetic Retinopathy Screening During the COVID-19 Pandemic. Telemedicine and e-Health. 2025;31(8):1019-1026. doi:10.1089/tmj.2024.0526
BibTeX
@article{Nguyen2025,
author = {Nguyen, Lindsey and Jaishankar, Trisha and Chokshi, Tanvi and Cruz, Maria Jessica and Kim, Joshua and Vargas-Ramos, Treysi and Snyder, Blake and Hang, Abraham and Guajardo, Lauren and Yiu, Glenn},
title = {Expansion in Teleophthalmology Use for Diabetic Retinopathy Screening During the COVID-19 Pandemic},
journal = {Telemedicine and e-Health},
year = {2025},
volume = {31},
number = {8},
pages = {1019--1026},
doi = {10.1089/tmj.2024.0526}
}
EUVIMED